Abu-Abaa Mohammad, Abdulsahib Ali, Al-Qaysi Ghassan, Arshad Hassaan
Internal Medicine, Internal Medicine Residency Program, Capital Health Regional Medical Center, Trenton, USA.
Internal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Cureus. 2023 Jan 23;15(1):e34103. doi: 10.7759/cureus.34103. eCollection 2023 Jan.
Both subarachnoid hemorrhage and intraparenchymal hemorrhage have been reported in patients with coronavirus disease 2019 (COVID-19) infection. We report a 38-year-old male patient who was initially admitted for alcoholic hepatitis and had a mild COVID-19 infection that was confirmed 10 days prior to presentation. During his hospitalization, he reported worsening of his occipital headache that started when he tested positive for COVID-19. Neurological examination was intact and no history of trauma, hypertension, illicit drug use, or family history of brain aneurysm was reported. Investigating his worsening headache revealed a tiny, right-sided, posterior subarachnoid hemorrhage. No coagulopathy was evident. No aneurysm was seen on the cerebral angiogram. The patient was managed conservatively. This case raises the point of the importance of investigating headaches even in mild COVID-19 infection, as it may herald intracranial bleeding.
2019冠状病毒病(COVID-19)感染患者中已报告有蛛网膜下腔出血和脑实质内出血情况。我们报告一名38岁男性患者,最初因酒精性肝炎入院,在就诊前10天确诊为轻度COVID-19感染。住院期间,他报告枕部头痛加重,自COVID-19检测呈阳性时起开始出现。神经系统检查正常,未报告有创伤、高血压、非法药物使用史或脑动脉瘤家族史。对其头痛加重情况进行检查发现有一处微小的右侧蛛网膜下腔出血。未发现明显的凝血功能障碍。脑血管造影未发现动脉瘤。该患者接受了保守治疗。此病例凸显了即使在轻度COVID-19感染时也应对头痛进行检查的重要性,因为这可能预示着颅内出血。